EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS): a retrospective longitudinal study of administrative claims data in Japan

Hiroyuki Takahashi, Shiori Yoshida, Akihiro Nakajima, Ruriko Koto, Hideaki Nakayama iD

Sleep and Breathing · 2025

DOI: 10.1007/s11325-025-03417-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Hiroyuki Takahashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science Department, Teijin Pharma Limited, Tokyo, Japan. hiroy.takahashi@teijin.co.jp. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Patient Compliance, Sleep Apnea Syndromes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Teijin Pharma Limited.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS) using administrative claims data in Japan.

Methods

We designed a retrospective longitudinal study using administrative claims and medical check-up data collected from April 2014 to February 2022. We identified patients newly starting CPAP therapy as their first-line SAS treatment, and assessed patient characteristics, CPAP persistence rates, predictors of CPAP discontinuation, and second-line therapy options.

Results

The analysis population ( n = 13,007) was 76.2% male, and the mean age (± standard deviation) was 64.0 ± 15.0 years. CPAP persistence rates were 90.1% at 90 days, 77.1% at one year, 70.3% at two years, and 66.5% at three years. More discontinuation was noted in patients aged 18 to 44 (adjusted hazard ratio [95% confidence interval]: 1.27 [1.13–1.42]) and ≥ 65 (65–74 years, 1.18 [1.07–1.30]; ≥75 years, 1.59 [1.43–1.76]) than in those aged 45 to 64. Comorbidities of dementia (1.47 [1.25–1.73]), insomnia (1.26 [1.16–1.36]), and restless legs syndrome (RLS, 1.60 [1.16–2.23]) were also associated with more discontinuation. Testing with a Type 3 portable monitor (1.31 [1.21–1.42]), or no record of sleep testing before therapy (1.21 [1.09–1.36]), tended to be associated with more discontinuation than polysomnography. CPAP therapy starting in 2020 (0.72 [0.63–0.82]) and 2021 (0.63 [0.46–0.85]) resulted in better persistence than that starting in 2016. Only 6.1% of patients received second-line therapy after CPAP discontinuation.

Conclusions

CPAP therapy was continued for at least a year by about 80% of patients. Because second-line therapies are rarely implemented, efforts are needed to ensure CPAP persistence by considering the factors that influence it. It is also crucial to raise awareness of alternative therapies. Registration number NA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Positive Airway PressurePatient ComplianceSleep Apnea SyndromesHumansMaleFemaleRetrospective StudiesMiddle AgedLongitudinal StudiesJapanAgedAdultYoung AdultAdolescentSleep Apnea, Obstructive

Stichwörter der Autor:innen

Continuous positive airway pressurePersistenceReal-world dataSleep apnea syndrome

Autor:innen und Institutionen

  • Medical Science Department, Teijin Pharma Limited, Tokyo, Japan. hiroy.takahashi@teijin.co.jp.
  • Clinical Development Control Department, Teijin Pharma Limited, Tokyo, Japan.
  • Medical Science Department, Teijin Pharma Limited, Tokyo, Japan.
  • Department of Somnology, Tokyo Medical University Hospital, Tokyo, Japan.

ORCID-Profile: Hideaki Nakayama

Förderung

  • Teijin Pharma Limited

Zitieren

APA

Takahashi, H., Yoshida, S., Nakajima, A., Koto, R., & Nakayama, H. (2025). Real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS): a retrospective longitudinal study of administrative claims data in Japan. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03417-w

Vancouver

Takahashi H, Yoshida S, Nakajima A, Koto R, Nakayama H. Real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS): a retrospective longitudinal study of administrative claims data in Japan. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03417-w

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Hiroyuki and Yoshida, Shiori and Nakajima, Akihiro and Koto, Ruriko and Nakayama, Hideaki},
  title = {Real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS): a retrospective longitudinal study of administrative claims data in Japan},
  journal = {Sleep and Breathing},
  year = {2025},
  doi = {10.1007/s11325-025-03417-w}
}
Kostenlos starten →